851
Views
37
CrossRef citations to date
0
Altmetric
Original Articles

Adherence to dornase alfa treatment among commercially insured patients with cystic fibrosis

, , , &
Pages 801-808 | Accepted 12 Mar 2013, Published online: 04 Apr 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Marie Viprey, Frédéric Mougeot, Alexandra Lelia Dima, Julie Haesebaert, Pauline Occelli, Isabelle Durieu, Héloïse Rouzé, Quitterie Reynaud & Sandrine Touzet. (2023) A Participatory Approach Involving Patients with Cystic Fibrosis and Healthcare Professionals for the Co-Design of an Adherence-Enhancing Intervention Toolkit. Patient Preference and Adherence 17, pages 995-1004.
Read now
Héloïse Rouzé, Marie Viprey, Samuel Allemann, Alexandra L Dima, Pascal Caillet, Angélique Denis, Stéphanie Poupon-Bourdy, Boubou Camara, Catherine Llerena, Philippe Reix, Isabelle Durieu, Quitterie Reynaud & Sandrine Touzet. (2019) Adherence to long-term therapies in cystic fibrosis: a French cross-sectional study linking prescribing, dispensing, and hospitalization data. Patient Preference and Adherence 13, pages 1497-1510.
Read now
Zhe Hui Hoo, Martin J Wildman, Michael J Campbell, Stephen J Walters & Benjamin Gardner. (2019) A pragmatic behavior-based habit index for adherence to nebulized treatments among adults with cystic fibrosis. Patient Preference and Adherence 13, pages 283-294.
Read now
Carla Colombo, Paola Catastini, Anna Brivio, Benedetto Acone, Patricia Dang & Serena Quattrucci. (2018) Delphi poll to assess consensus on issues influencing long-term adherence to treatments in cystic fibrosis among Italian health care professionals. Patient Preference and Adherence 12, pages 2233-2241.
Read now
Siva Narayanan, Jochen G. Mainz, Smeet Gala, Harold Tabori & Daniel Grossoehme. (2017) Adherence to therapies in cystic fibrosis: a targeted literature review. Expert Review of Respiratory Medicine 11:2, pages 129-145.
Read now
Julian S Tam & Elizabeth Tullis. (2014) Inhaled dry powder mannitol in cystic fibrosis. Expert Opinion on Orphan Drugs 2:7, pages 751-757.
Read now

Articles from other publishers (30)

Sohaib Mahri, Tobias Wilms, Paul Hagedorm, Marie-Julie Guichard, Kevin Vanvarenberg, Mireille Dumoulin, Henderik Frijlink & Rita Vanbever. (2023) Nebulization of PEGylated recombinant human deoxyribonuclease I using vibrating membrane nebulizers: A technical feasibility study. European Journal of Pharmaceutical Sciences 189, pages 106522.
Crossref
Sophie Dawson, Carla-Jane Girling, Lisa Cowap & David Clark-Carter. (2023) Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis. Cochrane Database of Systematic Reviews 2023:3.
Crossref
Carla Girling, Anna Packham, Louisa Robinson, Madelynne A. Arden, Daniel Hind & Martin J. Wildman. (2022) Implementing the use of objective medication adherence data in routine clinical practice via the digital CFHealthHub platform: situation analysis and strategy development using the theoretical domains framework. Implementation Science Communications 3:1.
Crossref
Elpis Hatziagorou, Katerina Manika, Syrmo Styliani Kyrvasili, Serafeim Chrysovalantis Kotoulas, Elisavet Anna Chrysochoou, Eleana Kouroukli, Maria Sionidou & John Tsanakas. (2022) Pulmonary medication adherence among children and adults with cystic fibrosis: Is there an association with disease severity?. Pediatric Pulmonology 57:12, pages 3017-3026.
Crossref
Katerina Manika, Elpis Hatziagorou, Serafeim‐Chrysovalantis Kotoulas, Syrmo‐Styliani Kyrvasili, Evdokia Sourla, Eleana Kouroukli, Maria Sionidou, Eleni Papadaki & John Tsanakas. (2022) Adherence to inhaled therapies over 4 years in people with cystic fibrosis. Pediatric Pulmonology 57:4, pages 956-964.
Crossref
Ruth Marian Mitchell, Andrew M Jones, Katie Stocking, Philip Foden & Peter J Barry. (2021) Longitudinal effects of ivacaftor and medicine possession ratio in people with the Gly551Asp mutation: a 5-year study . Thorax 76:9, pages 874-879.
Crossref
Afsoon Sepahzad, Deborah J. Morris-Rosendahl & Jane C. Davies. (2021) Cystic Fibrosis Lung Disease Modifiers and Their Relevance in the New Era of Precision Medicine. Genes 12:4, pages 562.
Crossref
Tamara del Corral, Roy La Touche, Maria Àngels Cebrià i Iranzo, Ricardo Olmos, Fernando Blanco-Royano & Ibai López-de-Uralde-Villanueva. (2020) Development and Validation of the AdT-Physio Scale: A Tool to Assess Adherence and Perception of Physical Therapist Intervention in Patients With Cystic Fibrosis. Physical Therapy 100:11, pages 2063-2074.
Crossref
Sophie Dawson, Lisa Cowap, David Clark-Carter & Carla-Jane Girling. (2020) Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis. Cochrane Database of Systematic Reviews.
Crossref
Emily F. Muther, Jennifer L. Butcher & Kristin A. Riekert. 2020. Cystic Fibrosis. Cystic Fibrosis 449 463 .
Alexandra L. Quittner, Michelle N. Eakin, Adrianne N. Alpern, Alana K. Ridge, Katherine A. McLean, Andrew Bilderback, Kristen K. Criado, Shang-En Chung & Kristin A. Riekert. (2019) Clustered randomized controlled trial of a clinic-based problem-solving intervention to improve adherence in adolescents with cystic fibrosis. Journal of Cystic Fibrosis 18:6, pages 879-885.
Crossref
Kevin W. Southern, John P. Clancy & Sarath Ranganathan. (2019) Aerosolized agents for airway clearance in cystic fibrosis. Pediatric Pulmonology 54:6, pages 858-864.
Crossref
Marie-Julie Guichard, David Kinoo, Anne-Sophie Aubriot, Nathalie Bauwens, Jordane Gougué, François Vermeulen, Patrick Lebecque, Teresinha Leal & Rita Vanbever. (2018) Impact of PEGylation on the mucolytic activity of recombinant human deoxyribonuclease I in cystic fibrosis sputum. Clinical Science 132:13, pages 1439-1452.
Crossref
Heather S. Kirkham, Francis Staskon, Nishita Hira, Darren McLane, Karl M. Kilgore, Alexis Parente, Seung Kim & Gregory S. Sawicki. (2018) Outcome evaluation of a pharmacy‐based therapy management program for patients with cystic fibrosis. Pediatric Pulmonology 53:6, pages 720-727.
Crossref
Gopi B. Shah, Linde De Keyzer, Joy A. Russell & Ashleigh Halderman. (2018) Treatment of chronic rhinosinusitis with dornase alfa in patients with cystic fibrosis: a systematic review. International Forum of Allergy & Rhinology 8:6, pages 729-736.
Crossref
Aarti Shakkottai, Niko Kaciroti, Lauren Kasmikha & Samya Z. Nasr. (2018) Impact of home spirometry on medication adherence among adolescents with cystic fibrosis. Pediatric Pulmonology 53:4, pages 431-436.
Crossref
Jeffery T. Zobell, Elizabeth Schwab, Dave S. Collingridge, Cody Ball, Robert Nohavec & Fadi Asfour. (2017) Impact of pharmacy services on cystic fibrosis medication adherence. Pediatric Pulmonology 52:8, pages 1006-1012.
Crossref
Marie-Julie Guichard, Harshad P. Patil, Salome Juliette Koussoroplis, Ruddy Wattiez, Teresinha Leal & Rita Vanbever. (2017) Production and characterization of a PEGylated derivative of recombinant human deoxyribonuclease I for cystic fibrosis therapy. International Journal of Pharmaceutics 524:1-2, pages 159-167.
Crossref
M. Fayon, Y. Ladipo, F. Galod?S. Debelleix & P. Reix. (2016) Atteinte respiratoire pr?coce dans la mucoviscidose. Archives de P?diatrie 23:12, pages 12S9-12S14.
Crossref
S. Pakhale, J. Baron, M. Armstrong, G. Tasca, E. Gaudet, S.D. Aaron, W. Cameron & L. Balfour. (2016) Lost in translation? How adults living with Cystic Fibrosis understand treatment recommendations from their healthcare providers, and the impact on adherence to therapy. Patient Education and Counseling 99:8, pages 1319-1324.
Crossref
Aarti Shakkottai, Kelley M. Kidwell, Monica Townsend & Samya Z. Nasr. (2015) A five-year retrospective analysis of adherence in cystic fibrosis. Pediatric Pulmonology 50:12, pages 1224-1229.
Crossref
Christopher M. Siracusa, Jamie Ryan, Lisa Burns, Yu Wang, Nanhua Zhang, John P. Clancy & Dennis Drotar. (2015) Electronic monitoring reveals highly variable adherence patterns in patients prescribed ivacaftor. Journal of Cystic Fibrosis 14:5, pages 621-626.
Crossref
Peter Jones, Stuart R Dalziel, Rain Lamdin, Jennifer L Miles-Chan & Christopher Frampton. (2015) Oral non-steroidal anti-inflammatory drugs versus other oral analgesic agents for acute soft tissue injury. Cochrane Database of Systematic Reviews.
Crossref
Stephen Jones, Rachael Curley, Martin Wildman, Robert W Morton & Heather E Elphick. (2015) Interventions for improving adherence to treatment in cystic fibrosis. Cochrane Database of Systematic Reviews.
Crossref
Gregory S. Sawicki, Karen S. Heller, Nathan Demars & Walter M. Robinson. (2015) Motivating adherence among adolescents with cystic fibrosis: Youth and parent perspectives. Pediatric Pulmonology 50:2, pages 127-136.
Crossref
Alexandra L. Quittner, Jie Zhang, Maryna Marynchenko, Pooja A. Chopra, James Signorovitch, Yana Yushkina & Kristin A. Riekert. (2014) Pulmonary Medication Adherence and Health-care Use in Cystic Fibrosis. Chest 146:1, pages 142-151.
Crossref
Deborah A O'Neil & Douglas Fraser-Pitt. (2014) Progress towards next-generation therapeutics for cystic fibrosis. Future Medicinal Chemistry 6:9, pages 1067-1079.
Crossref
Paula Lomas. (2014) Enhancing adherence to inhaled therapies in cystic fibrosis. Therapeutic Advances in Respiratory Disease 8:2, pages 39-47.
Crossref
Mark T. Jennings, Kristin A. Riekert & Michael P. Boyle. (2014) Update on Key Emerging Challenges in Cystic Fibrosis. Medical Principles and Practice 23:5, pages 393-402.
Crossref
Michelle N. Eakin & Kristin A. Riekert. (2013) The impact of medication adherence on lung health outcomes in cystic fibrosis. Current Opinion in Pulmonary Medicine 19:6, pages 687-691.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.